Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-10 4:14 pm Sale | 13G | ANTARES PHARMA INC AIS | Versor Investments LP | 0 0% | -8,849,711 (Position Closed) | View |
| 2022-05-06 12:09 pm Purchase | 13G | ANTARES PHARMA INC AIS | Versor Investments LP | 8,849,711 5.19% | 8,849,711 (New Position) | View |
| 2022-04-29 5:38 pm Purchase | 13D | ANTARES PHARMA INC AIS | Magnetar Financial LLC | 13,191,998 7.73% | 13,191,998 (New Position) | View |
| 2022-02-14 09:08 am Purchase | 13G | ANTARES PHARMA INC AIS | Rubric Capital Management LP | 10,800,000 6.35% | 10,800,000 (New Position) | View |
| 2022-02-01 5:08 pm Purchase | 13G | ANTARES PHARMA INC AIS | BlackRock Inc. BLK | 12,023,196 7.1% | 197,043 (+1.67%) | View |
| 2021-01-28 5:55 pm Purchase | 13G | ANTARES PHARMA INC AIS | BlackRock Inc. BLK | 11,826,153 7.1% | 353,321 (+3.08%) | View |
| 2020-02-14 1:16 pm Sale | 13G | ANTARES PHARMA INC AIS | ARMISTICE CAPITAL LLC | 0 0% | -10,300,000 (Position Closed) | View |
| 2020-02-11 07:07 am Sale | 13G | ANTARES PHARMA INC AIS | UBS Group AG UBS | 0 0% | -13,137,018 (Position Closed) | View |
| 2020-02-05 11:25 am Purchase | 13G | ANTARES PHARMA INC AIS | BlackRock Inc. BLK | 11,472,832 7% | 1,238,630 (+12.10%) | View |